IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

BASF Plans to “Ramp Up” Spending in Diagnostic Medicines

8:47 AM MDT | October 26, 2007 |

Alex Scott

BASF plans to “ramp up” spending to develop diagnostic and prognostic test products that have been designed by its human health biotech business Metanomics Health (Berlin), Peter Oakley, BASF board member responsible for Agricultural Products and Fine Chemicals, told journalists at a briefing in Berlin this week. The company is developing novel diagnostic tests including those that could predict the onset of certain diseases in people, such as diabetes, potentially enabling physicians to prevent the onset of a given disease in the first place. The...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa